It is worth noting that from the non-T2D signaling pathway, IL6 was characterized as an anti-inflammatory cytokine and indirectly interacted with ISL1 and SETD7 to activate PDX1, intensifying cell proliferation. Here, PDX1 is linked to type 2 diabetes mellitus.